1Wermers RA,Fatourechi V,Wynne AG,et al. The glucagonoma syndrome. Clinical and pathologic features in 21 patients [J]. Medicine,1996,75(2):53- 63.
2Yada K,Hirano S,Himeno Y,et al. Laparoscopic resection for nonfunctioning small glucagon-producing tumor: report of a case and review of the literature [J]. J Hepatobiliary Pancreat Surg,2003,10(5):382- 385.
4Sarmiento JM,Que FG,Grant CS,et al. Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach [J]. Surgery, 2002, 132(6):976- 982.
5Matthews BD,Smith TI,Kercher KW,et al. Surgical experience with functioning pancreatic neuroendocrine tumors [J]. Am Surg,2002,68(8):660- 665.
6Papotti M,Bongiovanni M,Volante M,et al. Expression of somatostatin receptor types 1- 5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis [J]. Virchows Arch,2002,440(5):461- 475.
7Chu QD,Al-kasspooles MF,Smith JL,et al. Is glucagonoma of the pancreas a curable disease? [J]. Int J Pancreatol,2001,29(3):155- 162.
8Tomassetti P,Migliori M,Lalli S,et al. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endo-crine tumours [J]. Ann Oncol,2001,12 (Suppl 2):S95- S99.
